BibTex RIS Cite

Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu

Year 2009, Volume: 40 Issue: 2, 53 - 62, 15.11.2013

Tülay İrez Sema Bilgiç Gazioğlu Özlem Tuğçe Çilingir Tülay İrez Mustafa Taşyürekli Sema Bilgiç Gazioğlu

Keywords

Kordon kanı hematopoetik kök hücre mononükleer hücre kriyoprezervasyon vitrifikasyon

References

  • 1. Okumufl N. Kordon kan› mononükleer hücrelerinin fenotipik karakterizasyonu ve NK aktivitesi. ‹stanbul Üniversitesi Sa¤l›k Bilimleri Enst. ‹mmünoloji Yüksek Lisans Tezi. ‹stanbul, 2003.
  • 2. Broxymeyer HE, Smith FO. Cord blood stem cell transplantation. In: Thomas D, Blume KG, Forman SJ, eds. Hematopoietic cell transplantation. 2nd ed. London: Blackwell; 1999. pp. 431-443.
  • 3. Nash RA. Hematopoietic stem cell transplantation. In: Lee GR, Forester J, Lukens J, Parakevas F, Greer JP, Rodgers GM, eds. Wintrobe’s Clinical Hematology. 10th ed. Baltimore: Williams and Wilkins; 1999. pp. 875-896
  • 4. Ramsey NKC. Bone marrow transplantation pediatric oncology. Pizzo PA, Poplack DG, eds. In Principle and Practice of Pediatric Oncology. 2nd ed. Philadelphia; Lippincott; 1993. pp. 314-344.
  • 5. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
  • 6. Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: releveance to umbilical cord blood transplantation. Br J Haematol 1995; 89: 733-740.
  • 7. Almici C. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood. Leukemia 1997; 11: 2143-2149.
  • 8. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828-3832.
  • 9. Wagner JE, De Fort T, Rubinstein P, et al. Transplantation of unreleated donor umbilical cord blood: outcomes and analysis of risk factors. Blood 1997; 90: 398-402.
  • 10. Laughlin MJ, Baeker JI, Bambach B, et al. Hematopoietic engrafment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
  • 11. Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 2002; 14:160-164.
  • 12. Gluckman E, Rocha V, Boyer Chammard A, et al. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Outcome of cordblood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373-381.
  • 13. Mc Guckin CP, Forraz N, Baradoz MO, et al. Production of stem cells with embryonic characteristics from human umblical cord blood. Cell Proliferation 2005; 38: 245.
  • 14. Dooley DC, Oppenlander BK, Xiano M. Analysis of primitive CD34- and CD34+ hematopoietic cells from adults: gain and loss of CD34 antigen by undifferantiated cells are closely linked to proliferative status in culture. Stem Cells 2004; 22: 556-569.
  • 15. Goodel M. CD34- or CD34+: does it really matter? Blood 1999; 94: 2545-2547.
  • 16. Chang H, Jensen L, Quesenberry P, et al. Standardizations of hematopoietic stem cell assays: a summary of workshops and working group meeting sponsored by National Heart Lung and Blood Institute and held at National Institutes of Health, Bethesta, MD, on September 8-9, 1998 and July 30, 1999. Exp Hematol 2000; 28: 743-752.
  • 17. Civin CI, Almeida-Porada G, Lee MJ, et al. Sustained, retransplantable multilineage engraftment of highly purified bone marrow adult stem cells in vivo. Blood 1996; 88: 4102-4109.
  • 18. Michallet M, Thiebaut A, Philip I, et al. Transplantation with selected autologous peripheral blood CD34+ Thy1+ hematopoietic stem cells (HSC) in multiple myeloma: impact of HSC dose on engrafment, safety and immun reconstitution. Exp Hematol 2000; 28: 858-870.
  • 19. Kreissig K, Krisch A, Serke S. Characterization and measurement of CD34- expressing haemopoietic cells. J of Haemattherapy 1994; 3: 263-289.
  • 20. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak MZ. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 2001; 19: 99-107.
  • 21. Sogo S, Inaba M, Ogata H, et al. Inducti›n of c-kit molecules on human CD34+/c-kit low cells: evidence for CD34+/c-kit low cells as primitive hematopoietic stem cells. Stem Cells 1997; 93: 2302-2307.
  • 22. Süzergöz F. Büyüme faktörleriyle uyar›lm›fl kordon kan› mononükleer hücrelerinin in vitro kültürlerde proliferasyonu ve immünfenotipik özelliklerinin incelenmesi. ‹stanbul Üniversitesi Sa¤l›k Bilimleri Ens., ‹mmünoloji Doktora Tezi. ‹stanbul, 2002.
  • 23. Simmons PJ, Torok Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991; 78: 2848-2853.
  • 24. Civin CI, Banquerigo ML, Strauss LC, et al. Antigenic analysis of hematopoiesis flow cytometric characterization of My 10 positive progenitor cells in normal human bone marrow. Exp Hematol 1987; 15: 10-17.
  • 25. Pasino M, Lanza T, Marotta F, et al. Flow cytometric and functional characterization of AC133 cells from human umbilical cord blood. BJ Haematol 2000; 108: 793-800.
  • 26. Dhot Col PS, Sirohi Maj D, Swamy Brig GLN. Collection, separation, enumeration and cryopreservation of umbilical cord blood haematopoietic stem cellsan experimental study. MJAFI 2003; 59: 298-301.
  • 27. Meyer TPH, Hofmann B, Zaisserer J, et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy 2006; 8: 265-276.
  • 28. Shreffler WG, Visness CM, Burger M, et al. Standardization and performance evaluation of mononuclear cell cytokine secretion assays in a multicenter study. BMC Immunology 2006; 7: 29.
  • 29. Chivu M, Diaconu CC, Bleotu C, Alexiu I, Brasoveanu L, Cerescu C. The comparison of different protocols for expansion of umbilical cord blood hematopoetic stem cells. J Cell Mol Med 2004; 8: 223-231.
  • 30. Todaro AM, Pafumi C, Pernicone G, et al. Haematopoietic progenitors from umbilical cord blood. Blood Purif 2000; 18: 144-147.
  • 31. Kekarainen T, Mannelin S, Laine J, Jaatinen T. Optimization of immunmagnetic separation for cord blood-derived HSCs. BMC Cell Biology 2006; 7: 30.
  • 32. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665-4978.
  • 33. Moezzi L, Pourfathollah AA, Alimoghaddam K, Soleimani M, Ardjmand AR. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplan Proc 2005; 37: 4500-4503.
  • 34. Ryu KH, Shin HY, Ahn HS, Kim YJ, Woo SY, Seoh JY. Comparison of efficiency of ex vixo expansion of whole blood mononuclear cells and purified CD34+ cells from human umbilical cord blood. Hematologica 2004; 89: 606-607.
  • 35. Abboud M, Xu F, LaVia M, et al. Study of early hematopoietic precursors in human cord blood. Exp Hematol 1992; 20: 1043-1047.
  • 36. Sousa T, Sousa ME, Godinho MI, et al. Umbilical cord blood processing: Volume reduction and recovery of CD34+ cells. Bone Marrow Transplant 1997; 19: 311- 313.
  • 37. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001; 3: 377-386.

Year 2009, Volume: 40 Issue: 2, 53 - 62, 15.11.2013

Tülay İrez Sema Bilgiç Gazioğlu Özlem Tuğçe Çilingir Tülay İrez Mustafa Taşyürekli Sema Bilgiç Gazioğlu

References

  • 1. Okumufl N. Kordon kan› mononükleer hücrelerinin fenotipik karakterizasyonu ve NK aktivitesi. ‹stanbul Üniversitesi Sa¤l›k Bilimleri Enst. ‹mmünoloji Yüksek Lisans Tezi. ‹stanbul, 2003.
  • 2. Broxymeyer HE, Smith FO. Cord blood stem cell transplantation. In: Thomas D, Blume KG, Forman SJ, eds. Hematopoietic cell transplantation. 2nd ed. London: Blackwell; 1999. pp. 431-443.
  • 3. Nash RA. Hematopoietic stem cell transplantation. In: Lee GR, Forester J, Lukens J, Parakevas F, Greer JP, Rodgers GM, eds. Wintrobe’s Clinical Hematology. 10th ed. Baltimore: Williams and Wilkins; 1999. pp. 875-896
  • 4. Ramsey NKC. Bone marrow transplantation pediatric oncology. Pizzo PA, Poplack DG, eds. In Principle and Practice of Pediatric Oncology. 2nd ed. Philadelphia; Lippincott; 1993. pp. 314-344.
  • 5. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
  • 6. Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: releveance to umbilical cord blood transplantation. Br J Haematol 1995; 89: 733-740.
  • 7. Almici C. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood. Leukemia 1997; 11: 2143-2149.
  • 8. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828-3832.
  • 9. Wagner JE, De Fort T, Rubinstein P, et al. Transplantation of unreleated donor umbilical cord blood: outcomes and analysis of risk factors. Blood 1997; 90: 398-402.
  • 10. Laughlin MJ, Baeker JI, Bambach B, et al. Hematopoietic engrafment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
  • 11. Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 2002; 14:160-164.
  • 12. Gluckman E, Rocha V, Boyer Chammard A, et al. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Outcome of cordblood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373-381.
  • 13. Mc Guckin CP, Forraz N, Baradoz MO, et al. Production of stem cells with embryonic characteristics from human umblical cord blood. Cell Proliferation 2005; 38: 245.
  • 14. Dooley DC, Oppenlander BK, Xiano M. Analysis of primitive CD34- and CD34+ hematopoietic cells from adults: gain and loss of CD34 antigen by undifferantiated cells are closely linked to proliferative status in culture. Stem Cells 2004; 22: 556-569.
  • 15. Goodel M. CD34- or CD34+: does it really matter? Blood 1999; 94: 2545-2547.
  • 16. Chang H, Jensen L, Quesenberry P, et al. Standardizations of hematopoietic stem cell assays: a summary of workshops and working group meeting sponsored by National Heart Lung and Blood Institute and held at National Institutes of Health, Bethesta, MD, on September 8-9, 1998 and July 30, 1999. Exp Hematol 2000; 28: 743-752.
  • 17. Civin CI, Almeida-Porada G, Lee MJ, et al. Sustained, retransplantable multilineage engraftment of highly purified bone marrow adult stem cells in vivo. Blood 1996; 88: 4102-4109.
  • 18. Michallet M, Thiebaut A, Philip I, et al. Transplantation with selected autologous peripheral blood CD34+ Thy1+ hematopoietic stem cells (HSC) in multiple myeloma: impact of HSC dose on engrafment, safety and immun reconstitution. Exp Hematol 2000; 28: 858-870.
  • 19. Kreissig K, Krisch A, Serke S. Characterization and measurement of CD34- expressing haemopoietic cells. J of Haemattherapy 1994; 3: 263-289.
  • 20. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak MZ. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 2001; 19: 99-107.
  • 21. Sogo S, Inaba M, Ogata H, et al. Inducti›n of c-kit molecules on human CD34+/c-kit low cells: evidence for CD34+/c-kit low cells as primitive hematopoietic stem cells. Stem Cells 1997; 93: 2302-2307.
  • 22. Süzergöz F. Büyüme faktörleriyle uyar›lm›fl kordon kan› mononükleer hücrelerinin in vitro kültürlerde proliferasyonu ve immünfenotipik özelliklerinin incelenmesi. ‹stanbul Üniversitesi Sa¤l›k Bilimleri Ens., ‹mmünoloji Doktora Tezi. ‹stanbul, 2002.
  • 23. Simmons PJ, Torok Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991; 78: 2848-2853.
  • 24. Civin CI, Banquerigo ML, Strauss LC, et al. Antigenic analysis of hematopoiesis flow cytometric characterization of My 10 positive progenitor cells in normal human bone marrow. Exp Hematol 1987; 15: 10-17.
  • 25. Pasino M, Lanza T, Marotta F, et al. Flow cytometric and functional characterization of AC133 cells from human umbilical cord blood. BJ Haematol 2000; 108: 793-800.
  • 26. Dhot Col PS, Sirohi Maj D, Swamy Brig GLN. Collection, separation, enumeration and cryopreservation of umbilical cord blood haematopoietic stem cellsan experimental study. MJAFI 2003; 59: 298-301.
  • 27. Meyer TPH, Hofmann B, Zaisserer J, et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy 2006; 8: 265-276.
  • 28. Shreffler WG, Visness CM, Burger M, et al. Standardization and performance evaluation of mononuclear cell cytokine secretion assays in a multicenter study. BMC Immunology 2006; 7: 29.
  • 29. Chivu M, Diaconu CC, Bleotu C, Alexiu I, Brasoveanu L, Cerescu C. The comparison of different protocols for expansion of umbilical cord blood hematopoetic stem cells. J Cell Mol Med 2004; 8: 223-231.
  • 30. Todaro AM, Pafumi C, Pernicone G, et al. Haematopoietic progenitors from umbilical cord blood. Blood Purif 2000; 18: 144-147.
  • 31. Kekarainen T, Mannelin S, Laine J, Jaatinen T. Optimization of immunmagnetic separation for cord blood-derived HSCs. BMC Cell Biology 2006; 7: 30.
  • 32. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665-4978.
  • 33. Moezzi L, Pourfathollah AA, Alimoghaddam K, Soleimani M, Ardjmand AR. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplan Proc 2005; 37: 4500-4503.
  • 34. Ryu KH, Shin HY, Ahn HS, Kim YJ, Woo SY, Seoh JY. Comparison of efficiency of ex vixo expansion of whole blood mononuclear cells and purified CD34+ cells from human umbilical cord blood. Hematologica 2004; 89: 606-607.
  • 35. Abboud M, Xu F, LaVia M, et al. Study of early hematopoietic precursors in human cord blood. Exp Hematol 1992; 20: 1043-1047.
  • 36. Sousa T, Sousa ME, Godinho MI, et al. Umbilical cord blood processing: Volume reduction and recovery of CD34+ cells. Bone Marrow Transplant 1997; 19: 311- 313.
  • 37. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001; 3: 377-386.
There are 37 citations in total.

Details

Primary Language Turkish
Journal Section Araştırmalar
Authors

Tülay İrez This is me

Sema Bilgiç Gazioğlu This is me

Özlem Tuğçe Çilingir Tülay İrez This is me

Mustafa Taşyürekli Sema Bilgiç Gazioğlu This is me

Publication Date November 15, 2013
Published in Issue Year 2009 Volume: 40 Issue: 2

Cite

APA İrez, T., Gazioğlu, S. B., Tülay İrez, Ö. T. Ç., Sema Bilgiç Gazioğlu, M. T. (2013). Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu. Cerrahpaşa Tıp Dergisi, 40(2), 53-62.
AMA İrez T, Gazioğlu SB, Tülay İrez ÖTÇ, Sema Bilgiç Gazioğlu MT. Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu. Cerrahpaşa Tıp Dergisi. November 2013;40(2):53-62.
Chicago İrez, Tülay, Sema Bilgiç Gazioğlu, Özlem Tuğçe Çilingir Tülay İrez, and Mustafa Taşyürekli Sema Bilgiç Gazioğlu. “Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu”. Cerrahpaşa Tıp Dergisi 40, no. 2 (November 2013): 53-62.
EndNote İrez T, Gazioğlu SB, Tülay İrez ÖTÇ, Sema Bilgiç Gazioğlu MT (November 1, 2013) Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu. Cerrahpaşa Tıp Dergisi 40 2 53–62.
IEEE T. İrez, S. B. Gazioğlu, Ö. T. Ç. Tülay İrez, and M. T. Sema Bilgiç Gazioğlu, “Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu”, Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, pp. 53–62, 2013.
ISNAD İrez, Tülay et al. “Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu”. Cerrahpaşa Tıp Dergisi 40/2 (November 2013), 53-62.
JAMA İrez T, Gazioğlu SB, Tülay İrez ÖTÇ, Sema Bilgiç Gazioğlu MT. Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu. Cerrahpaşa Tıp Dergisi. 2013;40:53–62.
MLA İrez, Tülay et al. “Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu”. Cerrahpaşa Tıp Dergisi, vol. 40, no. 2, 2013, pp. 53-62.
Vancouver İrez T, Gazioğlu SB, Tülay İrez ÖTÇ, Sema Bilgiç Gazioğlu MT. Kordon Kanı Hücrelerinin Saklanmasında Vitrifikasyon Metodu. Cerrahpaşa Tıp Dergisi. 2013;40(2):53-62.